DoseSpot, a developer of e-prescribing integration platforms for medical, dental, and telehealth software, announced that its software application has completed the required third-party Electronic Prescribing of Controlled Substances (EPCS) audit.
The audit was completed with the Drummond Group, a global software test and certification body that was approved by the U.S. Drug Enforcement Administration (DEA) to audit EPCS software applications.
DoseSpot President Greg Waldstreicher noted in a press release that his company worked to provide an easy-to-use interface.
"We strive to provide an easy-to-use e-prescribing interface, and our team has successfully incorporated the EPCS functionality without disrupting our existing user experience," Waldstreicher he stated.
DoseSpot prescribers will now have the ability to e-prescribe controlled substances in 49 states.
"In less than six months, New York will be the first state to mandate e-prescribing, including EPCS," Waldstreicher added. "We are committed to offering the best e-prescribing integration experience for our current and future software customers and have made the process for enabling EPCS incredibly easy."
%20nov12024.q9h8imREpF.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&w=100&auto=format%2Ccompress&q=70)
%20nov12024.q9h8imREpF.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=167&w=250&auto=format%2Ccompress&q=70)
